Braun Kathryn L, Fong Megan, Gotay Carolyn C, Chong Clayton D K
Public Health and Social Work, University of Hawai'i, Honolulu, HI 96813, USA.
Pac Health Dialog. 2004 Sep;11(2):146-53.
Previous examinations of breast cancer and survival in Hawai'i's 5 major ethnic groups have found that Native Hawaiian women have the highest breast cancer mortality rates. Although ethnic disparities in survival are reduced when age and stage at diagnosis are controlled for statistically, prior studies could not explain ethnic variation in survival among women who were diagnosed at the same stage. We examined variations in breast tumor characteristics for a multiethnic sample of 4,583 women diagnosed in 1990-1997 by stage and age group and extended previous multivariate analyses by adding a new prognostic variable: estrogen receptor (ER) and progesterone receptor (PR) status. Logistic regression was used to examine the influence of age, stage, and hormone status on 5-year survival. With a few exceptions, greater proportions of Native Hawaiian women were diagnosed both in later stages of disease and at earlier ages compared to women of other ethnicities, and smaller proportions of Native Hawaiians survived 5 years post diagnosis in each stage and age group. Surprisingly, greater proportions of Native Hawaiian women in all age groups had ER/PR positive tumors, which is a prognostic indicator for better, not worse, survival. Native Hawaiian women had an increased risk of death and Japanese women had an increased chance of survival after controlling for age, stage, and ER/PR status. Future studies should examine other reasons for better survival of Japanese women and worse survival of Native Hawaiian women, including socioeconomic status, access to health insurance, adequacy of recommended screening frequency, co-morbid conditions, treatment appropriateness and compliance, and genetic markers of tumor aggressiveness.
此前对夏威夷5个主要种族群体的乳腺癌及生存率的调查发现,夏威夷原住民女性的乳腺癌死亡率最高。尽管在对诊断时的年龄和阶段进行统计学控制后,生存率的种族差异有所减小,但之前的研究无法解释在相同阶段被诊断出的女性在生存率上的种族差异。我们针对1990年至1997年间被诊断出的4583名多族裔女性样本,按阶段和年龄组研究了乳腺肿瘤特征的差异,并通过添加一个新的预后变量:雌激素受体(ER)和孕激素受体(PR)状态,扩展了之前的多变量分析。使用逻辑回归来检验年龄、阶段和激素状态对5年生存率的影响。除了少数例外情况,与其他种族的女性相比,更大比例的夏威夷原住民女性在疾病的晚期阶段和较早年龄被诊断出,并且在每个阶段和年龄组中,夏威夷原住民女性在诊断后存活5年的比例较小。令人惊讶的是,所有年龄组中更大比例的夏威夷原住民女性患有ER/PR阳性肿瘤,而这是生存率更高而非更低的一个预后指标。在控制了年龄、阶段和ER/PR状态后,夏威夷原住民女性的死亡风险增加,而日本女性的生存机会增加。未来的研究应该探究日本女性生存率较高而夏威夷原住民女性生存率较低的其他原因,包括社会经济地位、获得医疗保险的情况、推荐筛查频率的充足性、合并症、治疗的适当性和依从性,以及肿瘤侵袭性的基因标记。